Biphasic sarcomatoid carcinoma or carcinosarcoma of the breast: prognosis and therapy.
Biphasic sarcomatoid carcinoma of the breast represents only 0.2% of all breast cancer. Due to its rarity and repetitive reclassifications little is known about optimal treatment modalities. These tumours form a diagnostic and therapeutic challenge. The present report describes our experience with a case of biphasic sarcomatoid carcinoma of the breast and a review of the relevant literature is discussed.
Cornette
J
J
Department of Gynaecology and Gynaecological Oncology, University Hospital Antwerp, Edegem, Belgium.
Tjalma
W A A
WA
Buytaert
P
P
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D002296:Carcinosarcoma / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011379:Prognosis